Showing results (101-110 of 120) with videos related to

Sort By:
Pageof 12
Plos One|June 6, 2017
Association between circulating fibroblast growth factor 21 and mortality in end-stage renal diseaseMarina Kohara, Takahiro Masuda, Kazuhiro Shiizaki, et al.
Internal Medicine (Tokyo, Japan)|October 12, 2016
Dual Impact of Tolvaptan on Intracellular and Extracellular Water in Chronic Kidney Disease Patients with Fluid RetentionTakahiro Masuda, Takuya Murakami, Yusuke Igarashi, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|October 1, 2025
SGLT2 inhibitor requires co-administration with diuretics to effectively reduce interstitial fluid retention: the DAPA-BODY trialTakahiro Masuda, Maki Asakura-Kinoshita, Kentaro Oka, et al.
Diabetology & Metabolic Syndrome|May 8, 2020
The extracellular volume status predicts body fluid response to SGLT2 inhibitor dapagliflozin in diabetic kidney diseaseKen Ohara, Takahiro Masuda, Masato Morinari, et al.
Clinical Medicine Insights. Case Reports|August 8, 2018
Hemolytic Uremic Syndrome: An Increasingly Recognized Public Health ProblemTakuya Murakami, Tetsu Akimoto, Tomoyuki Yamazaki, et al.
Clinical Medicine Insights. Case Reports|November 1, 2017
Pleuroperitoneal Communication and Ovarian Cancer Complicating Peritoneal Dialysis: A Case Report of a Patient with End-Stage Kidney DiseaseTetsu Akimoto, Tomoyuki Yamazaki, Marina Kohara, et al.
Internal Medicine (Tokyo, Japan)|July 16, 2025
Urinary β2-microglobulin as a Potential Biomarker for Early Treatment Selection: A Patient with Severe IgG4-related Tubulointerstitial NephritisNozomi Taniguchi, Masato Sakai, Takahiro Masuda, et al.
Clinical and Experimental Nephrology|March 26, 2011
Renal failure caused by plasma cell infiltration in multiple myelomaShiho Hanawa, Tetsu Akimoto, Eisuke Uehara, et al.
Pageof 12